Trial Profile
Recombinant Adenoviral Human p53 Gene With or Without Cisplatin in Treatment of Malignant Pleural - a Phase 2, Double Blinded, Randomized, Active Controlled Study
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Contusugene ladenovec (Primary) ; Cisplatin
- Indications Malignant pleural effusion
- Focus Therapeutic Use
- Sponsors Shenzhen SiBiono GeneTech
- 05 May 2015 New trial record